About Us

Twilight Venture Partners, LLC invests exclusively in early-stage biotech and med tech companies. Our Partners each have CEO-level experience, which we leverage to select outstanding companies and provide guidance to their management teams. Throughout our careers we have earned the trust and respect of clinicians, patients, regulators, and investors by bringing to market products that improve clinical outcomes and operating with uncompromised honesty.

A world-class reputation
TVP has unsurpassed scientific, clinical and entrepreneurial credibility. Building blocks of our reputation include: inventing, developing and launching several blockbuster drugs for Eli Lilly & Co.; chairing the Indiana University Medical School, the second-largest medical school in the U.S.; managing Eli Lilly's venture capital investments; and helping manage and direct Guidant Corporation. The visibility and experience of our Partners has allowed us to develop a complementary network with:

       • Pharmaceutical and medical devices corporations
       • Universities and research labs
       • Physicians and hospital administrators
       • Investment banks
       • Legal and accounting firms
       • Industry associations
       • Venture capital funds

Through our network, we receive and review hundreds of high quality proposals annually. TVP Partners sit on each of our portfolio companies' Board of Directors or Scientific Advisory Board, and actively participate in management.

TVP's investment criteria:
       • Focus within the life sciences industry
       • Experienced, proven entrepreneurs
       • Opportunity to serve in key management role(s)
       • Novel technology and defensible intellectual property
       • Significant potential market
       • Clear regulatory approval path

TVP primarily focuses on investment opportunities in Indiana and its surrounding states (Michigan, Illinois, Wisconsin, Ohio, and Kentucky), which are generally underserved by venture capital firms. Opportunistically, TVP pursues complementary investments nationally and globally.

TVP's proven program of active involvement includes:
       • Board of Directors participation
       • Serving as Chairman, CEO or senior executive
       • Recruiting and developing executive talent
       • Strategic planning and milestone setting
       • Creation of follow-on capital syndicates
       • Identification of and introductions to high quality strategic partners
       • Exit optimization

TVP's track record:

  • TVP has successfully invested in over ten portfolio companies since 2002 with several major exits, generating a superior internal rate of return
  • Partnering with TVP has provided portfolio companies access to a broad range of industry and capital sources
  • TVP has successfully partnered with the leading national life sciences venture capital firms on investments and with top-tier investment banking firms on exits
  • TVP has reinvested its profits in follow on investments and in new portfolio companies
  • TVP has co-founded highly promising companies such as EndGenitor Technologies, Inc. and Marcadia Biotech, Inc.